Sisram Medical Ltd (HKG:1696)
4.290
+0.100 (2.39%)
Mar 12, 2025, 4:08 PM HKT
Sisram Medical Revenue
Sisram Medical had revenue of $168.73M USD in the half year ending June 30, 2024, a decrease of -3.31%. This brings the company's revenue in the last twelve months to $356.40M, up 1.37% year-over-year. In the year 2023, Sisram Medical had annual revenue of $359.29M with 1.36% growth.
Revenue (ttm)
$356.40M
Revenue Growth
+1.37%
P/S Ratio
0.72
Revenue / Employee
$330.31K
Employees
1,079
Market Cap
2.01B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 359.29M | 4.81M | 1.36% |
Dec 31, 2022 | 354.48M | 60.19M | 20.45% |
Dec 31, 2021 | 294.29M | 132.20M | 81.56% |
Dec 31, 2020 | 162.10M | -11.43M | -6.58% |
Dec 31, 2019 | 173.52M | 19.60M | 12.73% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
JD Health International | 61.89B |
Hansoh Pharmaceutical Group Company | 13.00B |
WuXi Biologics | 18.39B |
Alibaba Health Information Technology | 31.39B |
Innovent Biologics | 8.01B |
Sino Biopharmaceutical | 29.86B |
Akeso | 2.01B |
Sisram Medical News
- 6 months ago - Sirsram Medical announces NMPA approval for DAXXIFY® - Benzinga